HearingSenate
[Errata] Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System
Held
Wednesday, April 27, 2016
Held by
Senate Aging (Temporary Special) Committee
Transcript
Held
Held by
Senate Aging (Temporary Special) Committee
Transcript